drugset / Trial / NCT00925678

DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

NCT00925678 ↗

Phase 1 Completed 72 enrolled Sumitomo Pharma Co., Ltd.
RandomizedDouble-blind

Summary

Investigate safety/tolerability after a single dose intranasal administration of DSP-3025 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season.

Timeline

Start
2009-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8848 Small molecule — Intranasal

Indications